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Background: Genes that decline in expression with age and are thought to coordinate growth cessation have
been identified in various organs, but their expression in skeletal muscle is unknown. Therefore, our objective was
to determine expression of these genes (Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1) in skeletal muscle from birth
to maturity. We hypothesized that expression of these genes would decline with age in skeletal muscle but differ
between sexes and between wild type and myostatin null mice.
Results: Female and male wild type and myostatin null mice (C57BL/6J background) were sacrificed by carbon
dioxide asphyxiation followed by decapitation at d -7, 0, 21, 42, and 70 days of age. Whole bodies at d -7, all
muscles from both hind limbs at d 0, and bicep femoris muscle from d 21, 42 and 70 were collected. Gene
expression was determined by quantitative real-time PCR. In general, expression of these growth-regulating
genes was reduced at d 21 compared with day 0 and d -7. Expression of Gpc3, Mest, and Peg3 was further
reduced at d 42 and 70 compared with d 21, however the expression of Mycn increased from d 21 to d 42 and
70. Myostatin null mice, as expected, were heavier with increased biceps femoris weight at d 70. However, with
respect to sex and genotype, there were few differences in expression. Expression of Ezh2 was increased at d 70
and expression of Mdk was increased at d 21 in myostatin null mice compared with wild type, but no other
genotype effects were present. Expression of Mdk was increased in females compared to males at d 70, but no
other sex effects were present.
Conclusions: Overall, these data suggest the downregulation of these growth-regulating genes with age might
play a role in the coordinated cessation of muscle growth similar to organ growth but likely have a limited role
in the differences between sexes or genotypes.
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As humans and animals age, growth slows and eventually
stops. Organs grow until they reach mature size; however,
little is known about how growth cessation is regulated
and coordinated in the body. A set of growth regulating
genes, which include Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3,
and Plagl1, has been identified that is dependent upon
growth and whose expression declines with age in organs
[1,2]. In general, when expression of these genes de-
creases, proliferation decreases leading to a reduction* Correspondence: adilger2@illinois.edu
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unless otherwise stated.in growth. Mutations of these genes also result in
reduced viability, growth abnormalities, and diseases such
as rhabdomyosarcoma, a skeletal muscle cancer, and
Simpson-Golabi-Behmel syndrome [3-18].
Though well characterized in organs, these genes have
not been well examined in growing muscle. It is expected
that expression of these genes would differ between
muscle, heart, and liver because of the differences in
how these tissues grow. Postnatally, muscle grows by
mainly hypertrophy, an increase in cell size, and not
hyperplasia, an increase in cell number [19]. In mice,
muscle fiber number becomes fixed at approximately d
7 postnatal [20]. Hypertrophy of muscle fibers is ac-
companied by satellite cell activation. These cells fusetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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[21,22]. Without the activation of satellite cells, postnatal
muscle growth and regeneration is severely inhibited. In
muscle, it is known that the expression of Ezh2, Mdk,
Mest, Peg3, and Plagl1 is increased during regeneration
[23-26]. In contrast, Mycn and Gpc3 have not been char-
acterized in muscle. Mycn, however, increases proliferation
of neural progenitor cells while Gpc3 is upregulated in the
early and middle stages of liver regeneration [27,28].
Because 5 of 7 of these genes are known to be upregulated
with muscle regeneration, it is possible that they are
involved in muscle growth by increasing activation, prolif-
eration, or differentiation of satellite cells. With age, the
expression of all of these genes is expected to decline in
both organs and muscle because the growth regulating
functions of these genes would be less necessary once
growth has ceased.
The objectives of this study were to 1) determine if these
7 genes were downregulated during postnatal growth
of skeletal muscle, 2) determine if expression differed
between male and female mice during this time period
and 3) determine if expression was altered by the absence
of myostatin. Myostatin null mice experience increased
muscle growth due to both increased hyperplasia and
hypertrophy [29] and exhibit increased satellite cell activ-
ity [30]. Furthermore, myostatin expression is decreased
with increasing age in rats [31], similar to the expression
patterns of genes in this study. Therefore, use of myostatin
null mice as a model for altered growth to determine the
influence of these genes is warranted. In general, we con-
firm that this set of genes is downregulated with age in
skeletal muscle of mice with minimal differences between
males and females. Expression of Ezh2 was increased at
d 70 and expression of Mdk was increased at d 21 in
myostatin null mice compared with wild type, but no
other genotype effects were present. These results suggest
that this set of genes may globally regulate the cessation of
growth in skeletal muscles as well as organs, but likely do
not contribute to differences in muscularity of myostatin
null mice.
Methods
All procedures were approved by the University of Illinois
Institutional Animal Care and Use Committee prior to
beginning the experiment.
Animal procedures and sample collection
Mice from an internal C57BL/6 J colony were allowed ad
libitum access to pelleted rodent chow (Teklad F6 rodent
diet, Harlan, Indianapolis, IN, USA) and tap water. Room
temperature was maintained at 22°C with a 12 hour light/
dark cycle. Male and female mice heterozygous for the
myostatin null mutation were bred in monogamous pairs
and litters were weaned at 21 days of age. Weaned micewere housed individually and genotyped with PCR based
genotyping [29]. At 0 (birth), 21, and 42 and 70 days of
age, 5 mice for each genotype by sex combination were
euthanized by CO2 asphyxiation and decapitation. Only 4
male wild type mice were collected at d 70. Pregnant dams
were also euthanized by CO2 asphyxiation and decapita-
tion 14 days after breeding (d -7) and 5 fetuses collected
to represent each genotype by sex combination. At d -7,
the entire mouse body was collected. At d 0, muscles from
both hindlimbs were combined. At all other time points,
biceps femoris muscles were weighed and collected.
Tissues were stored at -80°C until analysis.RNA Extraction and cDNA synthesis
Total RNA was extracted using TRI-Reagent (Sigma-Aldrich,
St. Louis, MO, USA) and BCP phase separation reagent
(Molecular Research Center, Inc., Cincinnati, OH, USA)
according to the manufacturers’ protocols. RNA purity and
concentration were measured using a NanoDrop 2000c
spectrophotometer (Thermo Scientific, Wilmington, DE,
USA). For cDNA synthesis, RNA was diluted to 500 ng/μl
using RNase-free water and 1 μg of RNA was reversed
transcribed using the qScript cDNA Super Mix (Quanta
Biosciences, Inc, Gaithersburg, MD).Quantitative real-time PCR
Validation experiments were conducted according to the
Applied Biosystems quantitative PCR manual (Applied
Biosystems, 2004) to determine the appropriate reference
gene (Rn18S) and cDNA dilution. Eighteen μl of a 1:100
dilution of cDNA, 2 μl of primer/probe, and 20 μl of
PerfeCTa® qPCR FastMix Reaction Mixes (Quanta Bio-
Sciences, Inc, USA) were mixed together and plated in
18 μl duplicates into a 96-well plate per reaction. Expres-
sion of Ezh2, Gpc3, Mdk, Mest, Mycn, Peg3, and Plagl1
(Table 1) was determined by quantitative real-time PCR
using a StepOnePlus Real-Time PCR System thermal
cycler (Life Technologies, Grand Island, NY, USA).
The thermal cycler performed an initial denaturation
at 95°C for 20 seconds followed by 40 cycles of 1 second
at 95°C and 20 seconds at 60°C. Expression was nor-
malized in two separate ways. First, to compare the ex-
pression of genes with increasing age, expression was
normalized to Rn18s (ΔCt) and compared to the average
of 70-day-old male wild type expression (ΔΔCt). To better
visualize the influence of sex and genotype on expression,
Ct values were normalized to Rn18s (ΔCt) and then com-
pared within the fetal and d 0 time points to the average
male wild type average of each time point (ΔΔCt). For 21,
42 and 70 d data, Ct values were normalized to Rn18s
(ΔCt) and then compared to the average male wild type at
21 d of age (ΔΔCt). Values were expressed as a fold
change (2-ΔΔCt = fold change) for statistical analysis.
Table 1 ABI primer/probe information
Gene symbol Gene name Gene bank reference sequence ABI assay ID
Ezh2 Enhancer of zeste homolog 2 NM_007971.2 NM_001146689.1 Mm00468464_m1
Gpc3 Glypican 3 NM_016697.3 Mm00516722_m1
Mdk Midkine NM_010784.4 Mm00440279_m1
Mest Mesoderm specific transcript NM_008590.1 Mm00484993_m1
Mycn V-myc myelocytomatosis viral related oncogene,
neuroblastoma derived
NM_008709.3 Mm00476449_m1
Peg3 Paternally expressed 3 NM_008817.2 Mm01337379_m1
Plagl1 Pleiomorphic adenoma gene-like 1 NM_009538.2 Mm00494250_m1
Rn18s 18S ribosomal RNA NR_003278.1 Mm03928990_g1
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Data were analyzed using the Proc Mixed procedure in
SAS version 9.2 (SAS Institute Inc., Cary, NC, USA).
The model included the fixed effects of age (when ap-
propriate), sex, and all 2- and 3-way interactions. Data
are presented as least squares means ± 95% confidence
intervals.
Results and discussion
Body and muscle weights
Body and muscle weights during postnatal growth were
compared between sexes and genotypes to illustrate
differences in growth patterns. At day 0 and 21, body
weights were similar among all genotype and sex com-
binations. Mice became heavier with age, and at d 70,
myostatin null mice were heavier than wild type mice
within sex while males were heavier than females within
genotype (Figure 1A). Bicep femoris weights were simi-
lar among all treatment groups at d 21 and 42, but
myostatin null muscles were heavier than wild type at
d 70 (Figure 1B). These results are similar to previous
reports of body and muscle weights of myostatin null
mice [29,32].
Expression of growth regulating genes in muscle
during growth
To determine the expression of these genes during growth,
the expression of all genes in wild type male mice was
analyzed in comparison to d 70 expression (Figure 2).
All genes were affected (P < 0.01) by age with an overall
decline of expression with increasing age. For all genes
except Mycn, expression was not different between d -7
and d 0; Mycn expression was reduced at d 0 compared
with d -7. In all genes, expression was reduced (P < 0.05)
at d 21, d 42 and d 70 compared with d -7 and d 0. Ex-
pression of Ezh2, Gpc3, Mdk, and Plagl1 did not decline
further after d 21. However, the expression of Mest, and
Peg3 was reduced (P < 0.05) at d 42 and 70 compared with
d 21, with expression at the later time points being similar.
For Mycn, expression was reduced (P < 0.05) at d 21compared with d 42 with expression at d 70 being
intermediate and similar to either time point. Therefore,
the results of previous experiments detailing the expres-
sion of these genes in various organs [1,2] are confirmed
in skeletal muscle. Expression of these genes declined
with age in wild type male mice.
Expression differences between sexes and genotypes
Expression of all 7 genes was unaffected by genotype or
sex at d -7 (Table 2). Similarly, at birth, expression of
Ezh2, Mdk, Mycn, and Plagl1 were unaffected by sex or
genotype (Table 3). Furthermore, expression of all genes
was unaffected by genotype. Expression of Gpc3, Mest
and Peg3 were increased in female mice compared with
male mice. There were no interactions (P < 0.05) of sex
and genotype for expression at d -7 or birth.
Expression data from d 21, 42 and 70 were compared
with the average wild type male expression at d 21 to
calculate fold changes. These data represent a consist-
ent muscle group as opposed to the previous data that
combine biceps femoris with whole hind limb or fetus
(Figure 3). Expression of Mdk and Plagl1 did not decline
with age from d 21 to 70. Expression of Ezh2, Gpc3, and
Peg3 were all increased (P < 0.05) at d 21 compared with
d 42 and 70, which were similar to each other. Expression
of Mest was increased (P < 0.05) at d 21 compared with d
42 and at d 42 compared with d 70. Expression of Mycn
actually increased with age as expression was increased
(P < 0.05) at d 42 and 70 compared with d 21.
Expression of all genes was unaffected by sex. Further-
more, with the exception of Mdk, expression was also
unaffected by genotype and interactions between genotype
with age or sex with age. Expression of Mdk was increased
(P ≤ 0.01) at d 21 in myostatin null mice compared with
wild type, but was similar between genotypes at d 42 or
70 (Figure 3). Expression of Mdk was also increased
(P ≤ 0.01) at d 70 in female mice compared with males,
but was similar between sexes at d 21 and 42 (data not
shown). Expression of Ezh2 at d 70 was also increased
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Figure 1 Body and tissue weights. Body weight (A) and muscle weight (B) of male wild type (open bars), female wild type (black bars), male
myostatin null (diagonal hatched bars) and female myostatin null mice (horizontal hatched bars). Plotted values are least squares means
displayed with 95% confidence interval bars.
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at d 70 between wild type and myostatin null mice,
only the expression of two genes differed at any time
point investigated and in both cases, gene expression
was increased in wild type, not the more heavily muscled
myostatin null mice. Therefore, these data suggest that
increases in satellite cell activity and hypertrophy noted in
myostatin null mice is not likely due to increased activity
in these growth promoting genes.
Nevertheless, we have confirmed that this suite of
genes is downregulated with age in skeletal muscle
similar to other organs. Ezh2, Mdk, Mest, Peg3, and Plagl1
are known to be involved in muscle regeneration and all
of the genes are overly expressed in rhabdomyosarcoma,
a skeletal muscle cancer [4-8,23,24,26,33]. It is possible
that these genes aid in postnatal muscle growth by acti-
vation, proliferation, or differentiation of satellite cells.Ezh2 has an established role in satellite cell activation
[24]; it can be speculated that Mdk, Mest, Peg3, and
Plagl1 might have similar functions because they are
also involved in muscle regeneration [23,26]. Mycn has
not been well characterized in muscle, but it promotes
the proliferation of neural progenitor cells and inhibits
neural differentiation and, therefore, might exhibit simi-
lar functions in muscle with regard to satellite cells [27].
Given these functions, it is expected that expression of
these genes would decrease with age as there is less acti-
vation, proliferation, and differentiation of satellite cells
and, thus, less need for the growth regulatory functions
of these genes as growth slows. In contrast, Gpc3 is
thought be a negative regulator of growth such that in-
creased expression results in reduced proliferation [28].
Gpc3 functions in muscle have not been identified; how-
ever, Gpc3 is involved in liver regeneration such that
Table 2 Effect of sex and genotype on gene expression
day -7 (14 d after matinga)
P-value
Gene Male Female Wild type Myostatin null Sex Genb Intb
Ezh2 0.988 1.249 1.273 0.969 0.62 0.56 0.60
Gpc3 1.515 1.073 1.158 1.403 0.34 0.60 0.09
Mdk 1.038 0.927 0.879 1.094 0.70 0.47 0.63
Mest 1.038 0.904 1.000 0.938 0.58 0.80 0.58
Mycn 1.155 0.939 1.007 1.077 0.62 0.87 0.59
Peg3 0.931 0.849 1.123 0.704 0.83 0.28 0.45
Plagl1 1.327 0.995 1.095 1.205 0.58 0.85 0.37
aValues are least squares means of fold changes. Fold change was compared
to the average wild type male expression.
bGen = Genotype, Int = Interaction of Sex and Genotype.
Table 3 Effect of sex and genotype on gene expression
birth (d 0)a
P-value
Gene Male Female Wild type Myostatin null Sex Genb Intb
Ezh2 0.647 0.924 0.649 0.916 0.95 0.92 0.17
Gpc3 0.853 1.253 1.114 0.960 <0.01 0.21 0.16
Mdk 0.733 0.763 0.848 0.659 0.89 0.39 0.22
Mest 1.057 1.503 1.263 1.257 0.01 0.97 0.31
Mycn 0.908 1.051 0.935 1.020 0.55 0.72 0.26
Peg3 0.805 1.076 1.018 0.851 0.03 0.17 0.06
Plagl1 1.135 1.439 1.211 1.348 0.21 0.57 0.44
aValues are least squares means of fold changes. Fold change was compared
to the average wild type male expression.
bGen = Genotype, Int = Interaction of Sex and Genotype.
Figure 2 Expression of growth regulating genes in muscle with age. Plotted values are least squares means displayed with 95% confidence
interval bars. Fold change is compared to the average wild type male 70-day-old expression.















































































































































Figure 3 Comparison of expression of growth regulating genes in skeletal muscle between genotypes at postnatal days 21, 42 and 70.
Plotted values are least squares means displayed with 95% confidence interval bars of wild type (open bars) and myostatin null (hatched bars)
mice. Fold change is compared to the average wild type male 70-day-old expression. Days lacking a common superscript (a,b,c) are different
(P < 0.05). **indicates that means within day are different (P ≤ 0.01) between genotypes.
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the process [28]. This leads to the conclusion that Gpc3
expression might increase early in postnatal develop-
ment to negatively regulate growth and proliferation, so
overgrowth of organs and muscle does not occur, and
decrease as growth slows because proliferation has de-
creased leading to less need for its regulatory functions.
Conclusions
In summary, this study examined the expression decline
of 7 growth regulating genes over time in the muscle of
wild type and heavily muscled myostatin null mice. Over-
all, expression was increased in all genes at the fetal time
point or birth compared with 21 d of age or later. Despitedifferences in muscle weights between wild type and
myostatin null mice, there were not widespread ex-
pression differences between genotypes, nor were there
differences between sexes. Therefore, differences observed
in muscle weights, especially between those of myostatin
null and wild type mice, do not seem to result from differ-
ential regulation of the growth-regulating genes examined
in this study. It should be noted, however, that the expres-
sion of these genes may be different in the satellite or stem
cell populations of skeletal muscle compared with the
skeletal muscle as a whole. Future work to differentiate
the role of these genes in satellite or stem cell prolifera-
tion, differentiation and fusion with existing muscle fibers
may be warranted.
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